.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
UBS
Chinese Patent Office
Harvard Business School
Cerilliant
Moodys
McKesson
QuintilesIMS
Boehringer Ingelheim

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021799

« Back to Dashboard
NDA 021799 describes QUALAQUIN, which is a drug marketed by Sun Pharm Inds and is included in one NDA. It is available from five suppliers. Additional details are available on the QUALAQUIN profile page.

The generic ingredient in QUALAQUIN is quinine sulfate. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

Summary for NDA: 021799

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 021799

Suppliers and Packaging for NDA: 021799

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUALAQUIN
quinine sulfate
CAPSULE;ORAL 021799 NDA AR Scientific Inc. 13310-153 13310-153-01 100 CAPSULE in 1 BOTTLE, PLASTIC (13310-153-01)
QUALAQUIN
quinine sulfate
CAPSULE;ORAL 021799 NDA AR Scientific Inc. 13310-153 13310-153-05 500 CAPSULE in 1 BOTTLE, PLASTIC (13310-153-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength324MG
Approval Date:Aug 12, 2005TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Baxter
Chubb
Moodys
AstraZeneca
Merck
Queensland Health
Federal Trade Commission
Colorcon
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot